Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Inhibrx Biosciences Inc shares valued at $11,287,500 were sold by VIKING GLOBAL INVESTORS LP on Oct 07 ’25. At $32.25 per share, VIKING GLOBAL INVESTORS LP sold 350,000 shares. The insider’s holdings dropped to 67,018 shares worth approximately $5.29 million following the completion of this transaction.
As published in their initiating research note from JMP Securities on July 23, 2024, Inhibrx Biosciences Inc [INBX] has been a Mkt perform.
Analyzing INBX Stock Performance
On last trading session, Inhibrx Biosciences Inc [NASDAQ: INBX] rose 1.31% to $79.0. The stock’s lowest price that day was $76.1, but it reached a high of $80.22 in the same session. During the last five days, there has been a surge of approximately 1.18%. Over the course of the year, Inhibrx Biosciences Inc shares have jumped approximately 426.32%. Shares of the company reached a 52-week high of $94.57 on 12/22/25 and a 52-week low of $10.81 on 04/11/25.
Support And Resistance Levels for Inhibrx Biosciences Inc (INBX)
According to the 24-hour chart, there is a support level at 76.57, which, if violated, would cause prices to drop to 74.15. In the upper region, resistance lies at 80.95. The next price resistance is at 82.91. RSI (Relative Strength Index) is 48.22 on the 14-day chart, showing neutral technical sentiment.
Is Inhibrx Biosciences Inc subject to short interest?
Stocks of Inhibrx Biosciences Inc saw a sharp steep in short interest on 2025-12-15 dropping by 86197.0 shares to 1.05 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 1.14 million shares. A decline of -8.21% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.58 of the overall float, the days-to-cover ratio (short ratio) decline to 4.58.